CPT code 10012: Fine needle aspiration biopsy, MRI guidance

Key takeaways

CPT code 10012 covers fine needle aspiration biopsy under MRI guidance, for each additional lesion after the first.

It is an add-on code, so it only pays when parent code CPT 10011 sits on the same claim.

The 2019 CPT restructuring deleted legacy code 10022 and replaced it with the series 10004 through 10012, split by imaging modality and lesion count.

Medicare carrier prices 10011 and 10012, so your contractor sets the allowed amount rather than a national fee schedule.

Practice management software like Pabau keeps the imaging report, lesion count, and diagnosis in one record, so an audit request is quick to answer.

CPT code 10012 is the add-on code for fine needle aspiration biopsy performed under MRI guidance, reported for each additional lesion after the first. It never travels alone. Medicare and most commercial payers reject the line unless parent code CPT 10011 appears on the same claim.

Two things then decide whether the claim pays. The note has to name MRI guidance explicitly, and the lesion count has to match the units billed. Medicare also carrier prices this code, so your contractor sets the rate instead of a national fee schedule.

CPT code 10012: definition and clinical description

Here is how the American Medical Association (AMA) defines the code. Fine needle aspiration biopsy, with magnetic resonance imaging (MRI) guidance; each additional lesion (List separately in addition to code for primary procedure). The plus sign prefix in the AMA CPT codebook confirms its add-on status.

In plain clinical terms, a radiologist or surgeon uses a thin needle to sample tissue or fluid from a suspicious lesion. MRI guides the needle in real time. CPT 10012 covers every lesion biopsied after the first in that same session.

Where 10012 sits in the FNA code series

CPT code 10012 belongs to the restructured fine needle aspiration biopsy series that took effect in 2019. Each code maps to one imaging modality and one lesion position, either the first lesion or each additional lesion. Reading the grid the wrong way is how a CT-guided session ends up billed as an MRI-guided one.

The series is symmetrical. Every modality has one primary code for the first lesion and one add-on code for each lesion after that. Swap the modality and you swap the pair, so an ultrasound session runs on CPT 10005 and 10006 instead.

Why CPT code 10022 was replaced in 2019

Before 2019, fine needle aspiration biopsy claims ran on two codes. CPT 10021 covered biopsies without imaging guidance, and CPT 10022 covered every biopsy that used imaging. Code 10022 bundled all the modalities into one descriptor, so the claim never showed whether the needle was guided by ultrasound or MRI.

The AMA deleted CPT 10022 effective January 1, 2019, and replaced it with the series 10004 through 10012. Each new code names one imaging modality and one lesion position, so payers can see the technique on the claim itself. A CT-guided first lesion now reports CPT 10009, and 10012 covers what 10022 used to hide, an MRI-guided second or subsequent lesion.

How to bill 10012 with parent code 10011

CPT code 10012 cannot be billed on its own, and that single rule drives most of the denials on this procedure. Every claim has to pair it with CPT 10011, the code for the first MRI-guided lesion in the session.

The billing logic works as follows:

1. Report CPT 10011 once for the first MRI-guided FNA lesion.
2. Report CPT code 10012 once for each additional lesion biopsied under MRI guidance in the same session.
3. If three lesions are biopsied under MRI guidance, bill 10011 x1 and 10012 x2.
4. Never report 10012 without 10011 on the same claim.
5. Never report 10012 for the first lesion, because that position always belongs to 10011.

Add-on codes are exempt from the multiple procedure payment reduction when they are reported with their designated parent code. Submit 10012 on its own and the payer edit rejects the line outright, so there is no exemption left to claim.

What the operative note has to document

Payers audit MRI-guided FNA claims closely, so the operative note and the imaging report have to carry specific language. Structured clinical documentation or digital intake forms that prompt for each data point leave fewer blanks to argue about later.

The documentation checklist for CPT code 10012:

• Imaging modality confirmed: The report must explicitly state MRI guidance was used (not CT, ultrasound, or fluoroscopy).
• Lesion count documented: The number of lesions sampled must be recorded. The first lesion must be identified, which supports 10011. Each additional lesion must be described on its own, which supports 10012.
• Anatomical site of each lesion: Location, laterality, and size for every lesion biopsied.
• Needle type and technique: Fine needle specified; aspiration method described.
• Real-time guidance documented: The note must state that imaging was performed in real time during needle placement, not just that imaging was reviewed beforehand.
• Specimen disposition: How the aspirate was handled (sent to cytopathology, on-site adequacy check, etc.).
• Medical necessity: The clinical indication for each individual lesion must appear in the note or a supporting order.

Missing any one of these elements gives a payer grounds to deny the claim or ask for a refund on audit. The ICD-10 codes on the claim have to correspond to each documented lesion site. Practices that sample skin and soft-tissue lesions daily, such as those running dermatology EMR software, work through this checklist several times a week.

Modifiers that apply to 10012

Several modifiers may apply to CPT code 10012 depending on the clinical scenario. Because 10012 is an add-on code, modifier application follows specific restrictions. Modifier 50 (bilateral procedure) is not applicable to add-on codes per CMS guidance. The table below covers the modifiers most likely to arise in practice.

Bundling rules and NCCI edits

The National Correct Coding Initiative (NCCI) governs which codes may be billed together. The Centers for Medicare and Medicaid Services (CMS) maintains it for Medicare and Medicaid claims. For 10012, the edits center on the aspiration code and any separately reported imaging guidance code.

Key bundling rules to know:

• MRI guidance is inherent to 10012: The MRI guidance component is included in the code descriptor. Do not separately report radiology imaging codes (such as 77021, MRI guidance for needle placement) on the same claim line as 10011 or 10012. Doing so triggers an NCCI bundle edit and results in denial of the imaging guidance code.
• Pathology codes are separately billable: CPT codes for cytopathology evaluation of the aspirate (e.g., 88172, 88173) may be reported separately when performed. These are not bundled with 10012.
• Anesthesia codes: Local anesthesia is considered part of the procedure and is not separately reportable. Moderate sedation or general anesthesia codes may be reported separately when medically documented.
• Same-session procedures: Other biopsy or excision work at a different site can be separately reportable when the documentation supports it. An open biopsy such as CPT 20251 or an excision such as CPT 11622 needs its own indication and operative detail. Add modifier 59 or XS where the edit applies.

Bundling edits change every quarter, so check the current file rather than a static list. The CMS NCCI edits page publishes the procedure-to-procedure tables for each quarter.

ICD-10 codes commonly paired with 10012

Medical necessity for CPT code 10012 rests on a diagnosis that justifies sampling more than one lesion under MRI. Most claims involve thyroid nodules, breast masses referred from primary care or an OB-GYN practice, enlarged lymph nodes, or soft-tissue lesions.

Each ICD-10 code on the claim has to match an individually documented lesion site in the operative note. One diagnosis code cannot carry three lesions unless the code itself describes a multinodular or multi-site condition.

How Medicare and commercial payers price 10012

Medicare does not publish a national price for CPT code 10012. Both 10011 and 10012 are carrier priced, which means each Medicare Administrative Contractor sets the allowed amount for its own jurisdiction. So there are no national work, practice expense, or malpractice RVUs to multiply by the conversion factor.

Start with your contractor’s own fee schedule. Where a contractor has not published a rate, it prices the claim case by case from the documentation you submit. Whatever it pays reflects the incremental work of each additional lesion, not the full procedure, which 10011 already covers.

What that means for a 2026 claim:

The CMS Physician Fee Schedule lookup tool confirms the carrier-priced status, then your contractor’s published schedule gives you the figure. A general RVU lookup returns nothing useful here, since the code has no RVUs to look up. For commercial work, check the add-on ratio written into each contract before you quote a multi-lesion session.

Common billing mistakes and denials

The most preventable denials for CPT code 10012 fall into six patterns. Review them before submitting any FNA claim that involves additional MRI-guided lesions. The same pairing logic governs the no-imaging codes, where CPT 10004 only pays alongside CPT 10021.

• Billing 10012 without 10011: The most common denial. 10012 is an add-on code and has no standalone status. CMS and most commercial payers will reject a 10012 claim that does not appear on the same claim with 10011.
• Missing or vague imaging documentation: “Imaging-guided biopsy” is not sufficient. The operative note must state MRI guidance specifically. Claims with generic language are flagged during audit and often denied retrospectively.
• Using modifier 50 on 10012: Modifier 50 (bilateral procedure) does not apply to add-on codes. Apply LT and RT modifiers separately when bilateral lesion sampling is documented.
• Reporting 10012 for the first lesion: The first MRI-guided FNA lesion is 10011. Billing 10012 for the first lesion is a code misassignment that results in denial and potential compliance risk.
• Separately reporting MRI guidance codes (e.g., 77021): MRI guidance is bundled into 10012. Adding a separate imaging guidance code triggers an NCCI edit and denial of one of the two codes.
• ICD-10 diagnosis mismatch: Each lesion needs its own supporting diagnosis. A single ICD-10 code that describes one lesion cannot justify billing for three separate lesion aspirations unless the code explicitly covers multiple or bilateral lesions.

How Pabau keeps FNA documentation and claims in step

Interventional radiology and surgical practices performing MRI-guided FNA usually keep the imaging report, the operative note, and the claim in three separate systems. Someone then retypes the lesion count from one into another. Pabau’s claims management software holds all three against one patient record.

For FNA billing specifically, the platform supports:

• Recording each add-on line beside the parent procedure, so the 10011 and 10012 pairing is visible before the claim leaves the practice.
• Prompting clinical staff to finish the required fields, from the imaging note to a signed HIPAA waiver form, before a claim is marked ready.
• Tracking modifier assignment per claim line, which lowers the risk of a wrong modifier landing on an add-on code.
• Keeping timestamped documentation with each submission, which supports payer audits and the record-keeping expected of HIPAA-compliant practice software.

For practices running interventional or radiology billing alongside broader practice management software needs, Pabau brings clinical documentation, scheduling, and claims into a single workflow.

Keep every FNA claim audit-ready

Pabau keeps the imaging report, lesion count, and diagnosis in one patient record, then sends the claim on to your clearinghouse without a re-key. Your billers work from the note instead of chasing it.

Book a demo

Conclusion

Treat 10012 as one half of a pair and most of the denial risk disappears. Bill it with 10011, name MRI guidance in the note, and keep modifier 50 off the line. The 2019 restructuring made the claim describe the technique, and payer edits now expect exactly that.

The pricing side needs a different habit. No national rate exists, so check what your contractor allows before you budget for multi-lesion MRI work. Revisit that figure whenever the local schedule changes, because nothing in the national file will tell you.

Pabau helps radiology and surgical billing teams keep the note and the claim line together, which is where these denials start. Book a demo to see how add-on code workflows look in one system.

Continue your research

Billing the first lesion in the same session? CPT 10011 sets out the parent code rules that decide whether your 10012 line pays.

Working from an ultrasound-guided session instead? CPT 10006 covers the add-on code for each additional lesion sampled under ultrasound.

Coding a breast biopsy rather than an aspiration? CPT 19083 explains ultrasound-guided breast biopsy billing and the documentation payers expect.

Excising a lesion after the cytology comes back? CPT 11624 walks through size-based excision coding for malignant lesions.

Sampling skin rather than deep tissue? CPT 11102 covers tangential skin biopsy billing and its own add-on code pairing.

Frequently asked questions